These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5650037)

  • 1. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
    Hildner FJ; Monto RW; Rebuck JW
    Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
    Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results obtained in the treatment of post-transfusional hemosiderosis with desferrioxamine ina case of hypoplastic congenital anemia of the Joseph-Blackfan-Diamon type].
    Nicolini A; Marca L; Pani C
    Minerva Pediatr; 1967 Aug; 19(34):1590-2. PubMed ID: 5610735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
    Tillmann W; König R; Schröder K; Schröter W
    Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
    Kaung DT
    J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A; Khalifa AS; Rahman YA; el-Bagoury I
    J Trop Med Hyg; 1969 Jan; 72(1):22-6. PubMed ID: 5773810
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
    Fujiyama N; Nakazawa K
    Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
    [No Abstract]   [Full Text] [Related]  

  • 8. Desferrioxamine and transfusional iron overload.
    Lancet; 1978 Mar; 1(8062):479-80. PubMed ID: 76025
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term study in congenital refractory anemia and secondary siderosis].
    Tuschy U; Schmidt U; Meinhold J; Wutke K
    Z Gesamte Inn Med; 1982 Apr; 37(7):213-7. PubMed ID: 7102009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
    [No Abstract]   [Full Text] [Related]  

  • 11. CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
    HILDNER FJ; MONTO RW; REBUCK JW
    Henry Ford Hosp Med Bull; 1964 Mar; 12():5-13. PubMed ID: 14129631
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of Cooley's anemia.
    Nathan DG
    Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
    [No Abstract]   [Full Text] [Related]  

  • 13. Desferal therapy in iron storage disease.
    Thompson RB; Owen DM; Bell WN
    Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitation of desferrioxamine treatment of transfusion hypersiderosis in children].
    Orsini A; Passeron P; Perrimond H; Pierron H
    Pediatrie; 1968; 23(5):588-9. PubMed ID: 5675452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
    Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
    Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved pituitary gonadotrophin response in adult transfusional haemosiderosis following desferrioxamine treatment.
    Waters AK
    Horm Metab Res; 1982 Jan; 14(1):55. PubMed ID: 7061039
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
    Hehlmann R; Schmitz H; Krüger K
    Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subcutaneous administration of deferoxamine in a patient with panmyelopathy and post-transfusion hemosiderosis].
    Zdziarska B; Urasiński I
    Pol Arch Med Wewn; 1987 Jul; 78(1):48-51. PubMed ID: 3271285
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
    Sidi Y; Shaklai M; Liban E; Pinkhas J
    Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.